Placebo therapy in rheumatoid arthritis

Area of Science:

• Rheumatology
• Psychology
• Clinical Pharmacology

Background:

• Chronic pain management in rheumatoid arthritis presents challenges.
• The influence of placebo therapy on pain perception requires further investigation.
• Understanding patient-specific factors influencing placebo response is crucial for clinical practice.

Purpose of the Study:

• To investigate the effect of placebo therapy on pain in rheumatoid arthritis patients.
• To identify potential predictors of placebo response, including personality traits and expectations.
• To explore the relationship between patient-reported outcomes and observed placebo effects.

Main Methods:

• Daily pain assessment over 25 days in 23 rheumatoid arthritis patients.
• Placebo administration during the final 9 days, with initial 16 days serving as baseline.
• Eysenck Personality Inventory, expectation, and post-treatment assessment scales administered.

Main Results:

• Nine patients showed positive placebo response, five showed negative response.
• Introverted patients reported no significant pain change, differing from positive and negative responders.
• Patient's assessment of therapeutic effect correlated with observed response; expectation did not.

Conclusions:

• Extraversion may serve as a predictor for placebo response in rheumatoid arthritis.
• Patient's subjective assessment, not initial expectation, relates to placebo outcome.
• Placebo variability underscores challenges in clinical judgment and drug efficacy trials.